Silo pharma to present at h.c. wainwright annual global investment conference

Presentation to feature silo's novel therapeutics for the underserved sarasota, fl, july 26, 2024 (globe newswire) -- silo pharma, inc. (nasdaq: silo) (“silo” or the “company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that ceo eric weisblum will present at the h.c. wainwright 25th annual global investment conference to be held september 9-11, 2024.
SILO Ratings Summary
SILO Quant Ranking